BridgeBio Pharma BBIO
NASDAQ BBIO
$65.80 -0.17 (-0.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Other Non-Current Liabilities (2018 - 2026)

Updated

BridgeBio Pharma's Other Non-Current Liabilities came in at $240,000 for Q2 2026, down 56.0% from $545,000 a year earlier but up 4.8% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma's Other Non-Current Liabilities was $244,000, down 14.7% from FY2024.

  • Other Non-Current Liabilities has declined in each of the last three years, with a five-year compound annual growth rate of -51.9% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Liabilities was $286,000 in FY2024 (-94.9%), $5.63 million in FY2023 (-78.9%), $26.64 million in FY2022 (+20.7%) and $22.07 million in FY2021 (+131.8%).
  • The five-year range for quarterly Other Non-Current Liabilities is $229,000 (Q1 2026) to $28.63 million (Q2 2022).
  • Year-over-year, Other Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 30.7% over the last eight quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q4 2021 (growth of 131.8%), and the weakest in Q3 2024 (a decline of 96.8%).
  • Business Quant data shows BBIO's Other Non-Current Liabilities at $229,000 (Q1 2026), $244,000 (Q4 2025) and $679,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 BridgeBio Pharma 12.88 Bn 10.00 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240,000.00
Mar 31, 2026 229,000.00
Dec 31, 2025 244,000.00
Sep 30, 2025 679,000.00
Jun 30, 2025 545,000.00
Mar 31, 2025 352,000.00
Dec 31, 2024 286,000.00
Sep 30, 2024 377,000.00
Jun 30, 2024 485,000.00
Mar 31, 2024 595,000.00
Dec 31, 2023 5.63 Mn
Sep 30, 2023 11.79 Mn
Jun 30, 2023 13.33 Mn
Mar 31, 2023 17.50 Mn
Dec 31, 2022 26.64 Mn
Sep 30, 2022 28.23 Mn
Jun 30, 2022 28.63 Mn
Mar 31, 2022 26.83 Mn
Dec 31, 2021 22.07 Mn
Sep 30, 2021 27.58 Mn
API Access

BridgeBio Pharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BBIO&period=max&api_key=YOUR_API_KEY